(Q36612299)

15 August 2017

1 reference

title

The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas (English)

1 reference

15 August 2017

The Therapeutic Role of Interferons and Monoclonal Antibodies in Cutaneous T-Cell Lymphomas (English)

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

2 November 2022

author name string

Bunn PA Jr

1

1 reference

15 August 2017

P. A. Bunn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701807

2 November 2022

D. A. Norris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701807

2 November 2022

language of work or name

English

0 references

publication date

1 December 1990

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:S0022202X9091223X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

https://api.elsevier.com/content/article/PII:S0022202X9091223X?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Journal of Investigative Dermatology

2 November 2022

published in

1 reference

15 August 2017

volume

95

1 reference

15 August 2017

issue

6 Suppl

1 reference

15 August 2017

page(s)

209S-212S

1 reference

Interferons: Rationale for Clinical Trials in Neoplastic Disease

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Interferons in the treatment of human cancer

2 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody

2 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody

2 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Cutaneous T cell lymphomas

2 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate

2 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study

2 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875762

2 November 2022

Identifiers

1 reference

Dimensions Publication ID

15 August 2017

1002887250

0 references

1 reference